Attention www.globalkeysolutions.net is now www.keypedia.com, read the full press release here.
KeyPedia LogoKeyPedia Icon
  1. Home
  2. /
  3. Records
  4. /
  5. Fda Inspections
  6. /
  7. Horizon Pharmaceuticals, Inc.
FDA Inspection
•Horizon Pharmaceuticals, Inc.•February 16, 2024

Horizon Pharmaceuticals, Inc. – FDA Inspection, Feb 16, 2024

Record Details

This FDA Inspection record concerns Horizon Pharmaceuticals, Inc., with an inspection on February 16, 2024, issued by the Center for Drug Evaluation and Research, covering drugs.

Company
Horizon Pharmaceuticals, Inc.
Inspection Date
February 16, 2024
Product Type
Drugs
Office
Center for Drug Evaluation and Research
People
  • Joanne E. King (FDA Associated Person)
  • Steven A. Brettler (FDA Associated Person)
View Company Profile

ID · 58e01881-1480-43d8-a97e-d7f79b53da41

Inspection Facts

Voluntary Action Indicated (VAI)

Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.

Inspection number
1230144
FDA center
Human Drugs
Project area
Drug Quality Assurance

FDA Citations

9
  1. 21 CFR 211.188Prepared for each batch, include complete information
  2. 21 CFR 211.198(b)(2)Complaint Investigation/Follow-Up Findings
  3. 21 CFR 211.160(b)(3)Drug product sample
  4. 21 CFR 211.160(b)Scientifically sound laboratory controls
  5. 21 CFR 211.194(a)(8)Identification of Person Performing Review of Lab Records
  6. 21 CFR 211.42(c)(10)Aseptic Processing Area
  7. 21 CFR 211.22(a)Authority lacking to review records, investigate errors
  8. 21 CFR 211.22(a)Contract drug products--lack of responsibility
  9. 21 CFR 211.22(d)Procedures not in writing, fully followed

Full citation text and observation details available on the Dashboard.

Other FDA inspections of Horizon Pharmaceuticals, Inc.

6
DateClassificationOfficeProject area
August 17, 2018VAICenter for Drug Evaluation and ResearchDrug Quality Assurance
August 5, 2017VAICenter for Drug Evaluation and ResearchDrug Quality Assurance
November 5, 2015OAICenter for Drug Evaluation and ResearchDrug Quality Assurance
May 17, 2013VAICenter for Drug Evaluation and ResearchDrug Quality Assurance
September 26, 2011VAICenter for Drug Evaluation and ResearchDrug Quality Assurance
View all 6 other inspections on the company page
Other documents for Horizon Pharmaceuticals, Inc.
  • FDA Inspection 1062610 - 2018-08-17
  • FDA Inspection 1021385 - 2017-08-05
  • FDA Inspection 947268 - 2015-11-05
  • FDA Inspection 834098 - 2013-05-17
  • FDA Inspection 747247 - 2011-09-26

Discuss this record with AI

KeyPedia

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore Horizon Pharmaceuticals, Inc.
KeyPedia
Regulatory Data Transformed
Stay in the loop

KRA score changes, company updates and news. About monthly, unsubscribe anytime.

Contact
New York Office:
370 Jay Street 7th Floor
Brooklyn, NY 11201
Scranton Office:
Scranton Enterprise Center, Suite 217
201 Lackawanna Avenue
Scranton, PA, 18503
🇺🇸+1 917-789-5099
🇪🇺+48 532-447-507
info@keypedia.com
Quick Links
HomePlatform OverviewMedia
KeyPedia™ Lite
Browse HubDatabase DirectoryRecordsCompaniesOfficesPeopleCareersAbout UsFounding TeamMeet Our ExpertsPartners
Legal & Ethics
Privacy PolicyTerms of ServiceOur Values & MissionCode of Ethics & AI Policy
©2026 KeyPedia™ | Global Key Solutions Corp. All rights reserved.